Sung-Soo Goh
Chief Executive Officer at Intercapital Co., Ltd.
Profile
Sung-Soo Goh is currently the Chief Executive Officer at Intercapital Co., Ltd.
He previously served as an Independent Director at Hanmi Pharmaceutical Co. Ltd., a Non-Executive Director at CrystalGenomics Invites Co., Ltd., an Independent Director at Hanmi Pharmaceutical Co., Ltd., a Director at DiNonA, Inc., and an Auditor at NDFOS Co., Ltd.
Goh holds an MBA from Purdue University and a doctorate from City University London.
Sung-Soo Goh active positions
| Companies | Position | Start |
|---|---|---|
| Intercapital Co., Ltd. | Chief Executive Officer | 2012-09-29 |
Former positions of Sung-Soo Goh
| Companies | Position | End |
|---|---|---|
Hanmi Pharmaceutical Co. Ltd. /Old/
 Hanmi Pharmaceutical Co. Ltd. /Old/ Pharmaceuticals: OtherHealth Technology Hanmi Pharmaceutical's principal activity is manufacturing of pharmaceuticals. Its products include OTC Drugs (Antiphlogistics, Analgesics, Remedies for Common Cold, Eye Drops, Vitamins and Nutrition), Prescription Drugs (Phthalmic Agents, Antifungal Agents, and Antibiotics), and Active Pharmaceutical Ingredients (APIs). | Director/Board Member | 2010-07-29 |
| DINONA INC. | Director/Board Member | - |
| NDFOS CO., LTD. | Comptroller/Controller/Auditor | - |
| HANMI PHARM. CO., LTD. | Director/Board Member | - |
| CRYSTALGENOMICS INVITES CO., LTD. | Director/Board Member | - |
Training of Sung-Soo Goh
| Purdue University | Masters Business Admin |
| City University London | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 3 |
|---|---|
| CRYSTALGENOMICS INVITES CO., LTD. | Health Technology |
| HANMI PHARM. CO., LTD. | Health Technology |
| NDFOS CO., LTD. | Process Industries |
| Private companies | 3 |
|---|---|
Hanmi Pharmaceutical Co. Ltd. /Old/
Hanmi Pharmaceutical Co. Ltd. /Old/ Pharmaceuticals: OtherHealth Technology Hanmi Pharmaceutical's principal activity is manufacturing of pharmaceuticals. Its products include OTC Drugs (Antiphlogistics, Analgesics, Remedies for Common Cold, Eye Drops, Vitamins and Nutrition), Prescription Drugs (Phthalmic Agents, Antifungal Agents, and Antibiotics), and Active Pharmaceutical Ingredients (APIs). | Health Technology |
DiNonA, Inc.
 DiNonA, Inc. Pharmaceuticals: MajorHealth Technology DiNonA, Inc. engages in the development of bio-drugs and medical devices. It operates through the Bio Medical and Medical Equipment business divisions. It offers antibody treatments, laser medical devices, and diagnostic reagents. The company was founded on February 11, 1999 and is headquartered in Seoul, South Korea. | Health Technology |
| Intercapital Co., Ltd. |
- Stock Market
- Insiders
- Sung-Soo Goh
